Axxelent Pharma Science
- CMO, CRO
Axxelent has Development and Manufacturing Capabilities of Oral Solids,Liquids,Semi-Solids,Injectables and Ophthalmic.
We have received EIR from the U.S. FDA for our Oral Solids in July 2024 and were inspected by Health Canada in Sept 2024 which was a successful outcome for the organization . We have started our Sterile Operations and will be triggering the inspections for the U.S., U.K., E.U., and Health Canada by end of this year. In Sterile we have the capability to develop and manufacture Injectables ( Vials, Ampoules and PFS ) and Ophthalmics .
We also have controlled substance license as well to meet your requirements.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}